It is likely that in these tumours, as in other cancers, MYCN reconfigures metabolism to favour aerobic glycolysis and a dependency on the serine-glycine-one-carbon (SGOC) to generate metabolic products starting from serine and glycine amino acids (181). Here, MYCN is linked to neoplasm.